Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks.
about
Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferScalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.AAV's anatomy: roadmap for optimizing vectors for translational successEpidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6.Gangliosides are essential for bovine adeno-associated virus entry.Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6Purification of host cell enzymes involved in adeno-associated virus DNA replication.Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity.Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942)Capsid antibodies to different adeno-associated virus serotypes bind common regions.Large animal models of neurological disorders for gene therapy.Adeno-associated virus enhances wild-type and oncolytic adenovirus spread.Targeted gene therapy for the treatment of heart failure.Adeno-associated virus structural biology as a tool in vector development.Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors.AAV serotypes have distinctive interactions with domains of the cellular receptor AAVR.Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints.Proteolytic mapping of the adeno-associated virus capsid.
P2860
Q33296224-6502DD0B-98F5-4FBA-86B8-133ED2BA445FQ33555259-E101FBF7-D9DA-465F-8DD4-CB51EF8E2989Q33659389-D7AB9445-B557-4E22-B2A6-C306A5DFD84BQ33913409-863DE314-90F8-4E0A-B3BA-41A918D95EF1Q34648299-2C2B2204-B429-4B7C-AE81-54D34FFC74CAQ35024289-1AF5910C-830E-43FA-A0D7-2DAF9C3507EAQ35857727-3A5E8527-CA26-47D9-A422-E471FAA05F00Q36424146-4047770E-754C-49BB-9A8F-70DE63131BFAQ36845958-7B979180-EB8D-4B51-A09A-4FD3D6BB4548Q37123344-2146BA15-E416-456C-A615-F7A62872235FQ37265519-B01D52B7-812E-4420-8B6E-59DDC19E901BQ37406907-A4BE3344-B854-45BC-A07B-2BF0E3D3EE01Q37878086-22AF1FA2-68CE-4E53-884B-4C64427CE3B6Q38188560-5FE027BC-20A1-4CBC-BC87-03ECA87258F4Q39884792-1CC4F23E-6861-412B-A1B6-80D0595B4A60Q40134100-A1C9F69E-0016-4B70-8780-ADC6D282A6C3Q42144221-13AA7B7D-BA49-48B6-8842-4A6F01BB460AQ42941986-EBCBE833-3CF0-4F05-A291-6C96522B3903
P2860
Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification and characteriz ...... isolates in ATCC virus stocks.
@ast
Identification and characteriz ...... isolates in ATCC virus stocks.
@en
Identification and characteriz ...... isolates in ATCC virus stocks.
@nl
type
label
Identification and characteriz ...... isolates in ATCC virus stocks.
@ast
Identification and characteriz ...... isolates in ATCC virus stocks.
@en
Identification and characteriz ...... isolates in ATCC virus stocks.
@nl
prefLabel
Identification and characteriz ...... isolates in ATCC virus stocks.
@ast
Identification and characteriz ...... isolates in ATCC virus stocks.
@en
Identification and characteriz ...... isolates in ATCC virus stocks.
@nl
P2093
P2860
P1433
P1476
Identification and characteriz ...... isolates in ATCC virus stocks.
@en
P2093
Charles Buck
Emmanuelle Grot
John A Chiorini
Michael Schmidt
Peter Cervenka
Sandra Wainer
P2860
P304
P356
10.1128/JVI.80.10.5082-5085.2006
P407
P577
2006-05-01T00:00:00Z